SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-025146
Filing Date
2019-07-17
Accepted
2019-07-17 16:03:21
Documents
3
Period of Report
2019-07-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fate-8k_20190715.htm 8-K 38794
2 EX-99.1 fate-ex991_6.htm EX-99.1 14677
3 GRAPHIC gfchekbhqpcf000001.jpg GRAPHIC 3659
  Complete submission text file 0001564590-19-025146.txt   59980
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36076 | Film No.: 19959185
SIC: 2836 Biological Products, (No Diagnostic Substances)